POWW.NASDAQAmmo, INC

Form 4: Ammo Inc. Director Richard Reed Childress Receives Stock Grant as Part of Board Compensation

Sentiment:

SEC Form 4


Director Richard Reed Childress reports receiving 15,000 shares of AMMO, Inc. common stock as part of his quarterly board compensation.

Summary

  • Richard Reed Childress, a director of AMMO, Inc., reported a transaction on July 11, 2024, where he acquired 15,000 shares of common stock.
  • These shares were granted as part of the quarterly compensation for his service on the Board of Directors.
  • The price per share was $0, indicating it was a grant.
  • Following this transaction, Childress directly owns 302,500 shares of AMMO, Inc.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of a stock grant, which is neither particularly positive nor negative. It's a standard part of director compensation.

Positives

  • The director's increased stake in the company could align his interests more closely with those of shareholders.

Industry Context

This type of stock grant is a common practice for compensating board members in publicly traded companies.

Comparison to Industry Standards

  • Stock grants for board members are a typical component of compensation packages in publicly traded companies.
  • The size of the grant can vary widely depending on the company's size, industry, and performance.
  • Comparing AMMO, Inc.'s board compensation structure to similar companies in the firearms and ammunition industry would provide a better benchmark.

Key Dates

DateDescription
07/11/2024Date of the stock grant transaction
07/15/2024Date of signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.